Incruse Ellipta 00173-0873
Generic: Umeclidinium
Product NDC
00173-0873- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Aerosol, Powder
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2014
- Listing Expires
- December 31, 2027
- Application
- NDA205382
Need to source Incruse Ellipta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Umeclidinium Bromide | 62.5 ug/1 |
Drug Class
Anticholinergic [EPC]Cholinergic Antagonists [MoA]
Packaging Options(2)
1 TRAY in 1 CARTON (0173-0873-06) / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALER
1 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER